Department of Obstetrics and Gynecology, Boston University School of Medicine/Boston Medical Center (RB Perkins), Boston, Mass.
American Cancer Society, Vaccinate Adolescents Against Cancer Program (S Foley, A Hassan, S Preiss, JI Witt, and M Fisher-Borne), Atlanta, Ga.
Acad Pediatr. 2021 Sep-Oct;21(7):1134-1141. doi: 10.1016/j.acap.2021.05.018. Epub 2021 May 20.
To evaluate the effectiveness of a multilevel intervention using national partnerships on human papillomavirus (HPV) vaccination rates.
The American Cancer Society's Vaccinate Adolescents against Cancer program is a multilevel intervention focusing on systems and providers. The 2017 cohort introduced national partnerships to deliver intervention elements and Maintenance of Certification and continuing medical education credits for physicians. Eleven federally qualified health center (FQHC) systems completed interventions in 2017. Interventions included provider training and ≥1 other evidence-based systems improvement. We compared adolescent vaccination rates in the preintervention period (2016) and intervention period (2017) among adolescents who turned 13 during the calendar year. Intervention effectiveness was assessed using repeated measures paired t tests and Cohen's d effect size for vaccination rate change.
All FQHC systems implemented provider training plus an average of 2.3 additional systems improvements. Series initiation increased by an average of 23.6 percentage points (47.2%-70.8%). HPV completion rates increased by an average of 22.7 percentage points (24.6%-46.3%). Meningococcal and Tdap vaccination rates increased by 23.3 and 25.9 percentage points respectively (47.9%-71.2% and 48.8%-74.7%). All changes were statistically significant (all P < .05) and indicated large effect sizes (Cohen's d 1.15). Among clinicians completing postintervention surveys, 90% reported making changes to their health care system or direct patient care based on what they had learned.
Multilevel interventions focusing on provider training and systems changes can substantially improve on-time adolescent vaccination coverage and can be successfully performed using national partnerships and a train-the-trainer model.
评估利用国家伙伴关系提高人乳头瘤病毒(HPV)疫苗接种率的多层次干预措施的效果。
美国癌症协会的“青少年癌症疫苗接种计划”是一项多层次干预措施,重点是系统和提供者。2017 年的队列引入了国家伙伴关系,为医生提供干预要素和继续医学教育学分的维护认证。11 个联邦合格的健康中心(FQHC)系统在 2017 年完成了干预措施。干预措施包括提供者培训和≥1 个其他基于证据的系统改进。我们比较了在日历年度中年满 13 岁的青少年在干预前(2016 年)和干预期间(2017 年)的青少年疫苗接种率。使用重复测量配对 t 检验和 Cohen's d 效应量评估干预效果的变化。
所有 FQHC 系统都实施了提供者培训,外加平均 2.3 项其他系统改进。系列启动率平均增加了 23.6 个百分点(47.2%-70.8%)。HPV 完成率平均增加了 22.7 个百分点(24.6%-46.3%)。脑膜炎球菌和 Tdap 疫苗接种率分别增加了 23.3 和 25.9 个百分点(47.9%-71.2%和 48.8%-74.7%)。所有变化均具有统计学意义(均 P <.05),且表明效应量较大(Cohen's d 1.15)。在完成干预后调查的临床医生中,90%的人报告根据他们所学的内容对他们的医疗保健系统或直接患者护理进行了更改。
专注于提供者培训和系统变革的多层次干预措施可以大大提高青少年按时接种疫苗的覆盖率,并且可以利用国家伙伴关系和培训师模式成功实施。